SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001437749-21-002824
Filing Date
2021-02-12
Accepted
2021-02-12 16:47:25
Documents
2
Group Members
DUGABOY INVESTMENT TRUSTJAMES D. DONDERONEXPOINT ADVISORS, L.P.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G highfund20210211_sc13g.htm SC 13G 129797
2 EXHIBIT 99.1 ex_226104.htm EX-99.1 10113
  Complete submission text file 0001437749-21-002824.txt   141954
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Subject) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81821 | Film No.: 21628737
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 CRESCENT COURT SUITE 700 DALLAS TX 75201
Business Address 300 CRESCENT COURT SUITE 700 DALLAS TX 75201 972-628-4100
HIGHLAND CAPITAL MANAGEMENT FUND ADVISORS, L.P. (Filed by) CIK: 0001469877 (see all company filings)

IRS No.: 264245035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G